Safety and Efficacy Study of Novel Gene Therapy AGX-08 for Geographic Atrophy
Clinical trial NCT07602127 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07602127
- Sponsor
- Zhongmou Therapeutics
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-12-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.